SUMMARY The immune response against two herpesviruses has been determined in sera and matched synovial fluids of patients with rheumatoid arthritis (RA) and compared with that of a healthy control population. The increased level of antibody to Epstein-Barr virus (EBV) induced antigens in patients with RA resembles the antibody pattern observed against cytomegalovirus (CMV) induced antigens, which suggests the presence of a pathological condition in patients with RA that can reactivate latent viral infections. The antibody response against EBV and CMV observed in synovial fluids excludes the local production of specific antibodies against EBV and CMV antigens.
Several pieces of indirect evidence have suggested a possible role for viruses in the pathogenesis of rheumatoid arthritis (RA). Although it has been argued recently that parvovirus infection may be the initial cause of rheumatoid arthritis,' the EpsteinBarr virus (EBV) has more frequently been postulated as a causative agent. As is known, EBV is an ubiquitous member of the Herpesviridae family, and its infection is often asymptomatic. In fact, by the time of young adulthood, most people have serum antibodies to EBV, which are markers of prior infection. In addition, together with the other herpesviruses, EBV shares the capacity of remaining latent in infected individuals until an appropriate stimulus or a lowering of immune barriers, or both, causes the reactivation of the latent infection. 
